Stocktoria
CareDx, Inc. CDNA
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2014-07-17
CareDx, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $379.8M | $333.8M | $280.3M | $321.8M | $296.4M |
| R&D expense | $71.4M | $72.5M | $82.4M | $90.4M | $76.5M |
| Operating income | -$30.8M | $40.8M | -$203.4M | -$77.2M | -$29.7M |
| Income tax | $271,000 | $310,000 | $141,000 | $379,000 | -$1.4M |
| Net income | -$21.4M | $52.5M | -$190.3M | -$76.6M | -$30.7M |
| EPS (diluted) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 |
| Operating cash flow | $42.0M | $38.0M | -$18.4M | -$25.2M | -$19.3M |
| Cash & equivalents | $65.4M | $114.7M | $82.2M | $89.9M | $348.5M |
| Inventory | $26.7M | $19.5M | $19.5M | $19.2M | $17.2M |
| Total assets | $413.2M | $491.1M | $466.8M | $543.0M | $566.6M |
| Total liabilities | $110.1M | $112.6M | $205.5M | $112.1M | $100.7M |
| Shareholders' equity | $303.1M | $378.4M | $261.3M | $430.9M | $465.9M |
Source: SEC EDGAR filings · CIK 0001217234 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.